GM three-lens brief
Evidence-based stock research on GM. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Analyst mean target $94.15 — 21% above current (26 analysts). · Debt-to-equity of 208.3 — balance-sheet-heavy.
- Analyst mean target $94.15 — 21% above current (26 analysts).
- Debt-to-equity of 208.3 — balance-sheet-heavy.
GM closed at $78.05 (-0.60%) as of 2026-04-25. Market cap: $70.37B. P/E (trailing) 23.9. Positives: analyst mean target $94.15 — 21% above current (26 analysts).. Concerns: debt-to-equity of 208.3 — balance-sheet-heavy.. Last quarter: Revenue $45.29B, net income -$3.33B, free cash flow $8.56B.
Why three lenses on GM, not one.
A single reasoning model has blind spots it doesn’t know about. We examine GMacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/GM" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath GM brief"></iframe>